IVIG for Lyme

Discussion in 'Lyme Disease Archives' started by ulala, Feb 17, 2008.

  1. ulala

    ulala New Member

    Has anyone had IVIG treatment? I've had it in the past and it really seemed to help me, but then was not able to get it because of shortages. I'm going to try again.

    January 09, 2008
    Interesting Use of IVIG in a Co-Infection Case

    Excerpted from The Journal of the American Board of Family Medicine 21 (1): 75-77 (2008). DOI: 10.3122/jabfm.2008.01.060182

    Complications of Coinfection with Babesia and Lyme Disease After Splenectomy
    Ya'aqov Abrams, MD, the Department of Family and Community Medicine, University of Pittsburgh, PA

    The patient is a 58-year-old man who had a trauma-related splenectomy 25 years ago. In August 2002 he presented to the office with several days of fluctuating fevers of 102° F or higher, rash, malaise, chills, and sweats. He spent a week at Cape Cod before a trip abroad to Brazil, from which he had just returned.

    His symptoms developed after the first week in Rio de Janeiro, Brazil. He recalled having no mosquito or other insect bites while in Brazil or Cape Cod. His temperature was 100.5° F and he had an eyrthema multiforme-like macular rash on his back and abdomen.

    An infectious disease specialist was consulted. Laboratory studies were notable for bandemia of 11%, mildly elevated liver injury tests, normal bilirubin, negative babesiosis, ehrlichia, Rocky Mountain Spotted Fever and typhus immunoglobulin IgG and IgM antibody titers, negative hepatitis A and hepatitis B titers, and a negative thick smear for intra-erythrocytic parasites.

    He was prescribed doxycycline but did not improve. Twelve days after presentation he noted myalgias with associated difficulty walking and was seen in the emergency department. Intra-erythrocytic parasites were noted on a thick blood smear; malaria was diagnosed and the patient was prescribed oral chloroquine.

    One day later the diagnosis was changed to babesiosis and treatment was changed to oral clindamycin and quinine. Several days later the patient was hospitalized with dark-colored urine and Babesia parasitemia of 4%. He initially received intravenous quinine and clindamycin, but he did not respond and treatment was changed to atovaquone, azithromycin, and a 2-week course of doxycycline.


    He developed adult respiratory distress syndrome, presumably from a Babesia parasitemia now up to 16%; this necessitated an exchange transfusion. The myalgias and weakness worsened and primary demyelinating polyneuropathy was diagnosed on electromyography.

    A magnetic resonance image of the brain was normal but serum IgM and Western Blotting were positive for Lyme disease. Despite a 1-month course of ceftriaxone, neuropathic symptoms did not improve until he received a 5-day course of intravenous immune globulin (IVIG).

    His fever and malaise were most likely caused by babesiosis; his rash is best explained by stage 2 Lyme disease (note that rash is not a feature of babesiosis or malaria).

    Given his medical and travel histories, a peripheral blood smear showing intra-erythrocytic parasites was most suggestive of babesiosis. Peripheral blood smear is the definitive method of diagnosis of babesiosis, but thin blood smears are usually required to distinguish between the trophozoites of Babesia and Malaria.

    Although neuroborreliosis may respond to IVIG, it is not known by what mechanism patients respond. IVIG has an off-label indication for therapy of neuroborreloisis.

    In the last published report on this topic, Crisp and Ashby proposed that the immune-modulating properties of IVIG might ameliorate Lyme disease by any of the following mechanisms: inhibition of cytokines, competition with autoantibodies, inhibition of complement deposition, interference with Fc receptor binding on macrophages or B-cells, or interference with T-cell recognition of antigens.*

    This case highlights the importance of a precise and detailed travel history in the febrile traveler and, in particular, one who has a history of splenectomy.

    Patients with immunocompromised systems are at greater risk for a more prolonged and severe courses of illness, especially with multiple infectious etiologies, illustrated here with Lyme disease and babesia.

    Finally, when treating any disease it is valuable to know which treatments are based on reliable research, such as the antibiotic choices for babesiosis and Lyme disease, and those which are anecdotal, such as IVIG treatment of neuroborreliosis.



  2. Nimzovich76

    Nimzovich76 New Member

    IVIG is experimentally used in a variety of autoimmune conditions and proven in many cases to be very effective. The more logical explanation here is that IVIG helped in balancing the immune system that was disturbed after these infections were treated. Lucky guy that other alternatives where treated immediately otherwise we would've ended up with an unexplained chronic disease (ME). Did you notice that they didn't have to send his blood to Igenex?